Solubacter 1%

Quick links to important sections

Solubacter 1%

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Solubacter 1%

Quick Facts

Property Description
Active ingredient Triclocarban (TCC)
Form Aqueous solution
Pharmacological class Antiseptic, Antimicrobial Agent
General purpose Topical hygienic cleaning
Origin Synthetic diarylurea compound

Solubacter 1%: Definition, Composition, and Pharmacological Class

Solubacter 1% is a pharmaceutical preparation classified as an antiseptic and antimicrobial agent intended for external application. Its core composition features the sole active ingredient, Triclocarban (TCC), precisely controlled at a 1% concentration within the solution.

The compound Triclocarban is a synthetic diarylurea derivative whose structure is supported by pharmacological data. This chemical classification places Solubacter 1% within a group of agents that possess broadly recognized antimicrobial properties. Triclocarban is primarily recognized for its activity against certain microorganisms, which is clinically recognized for supporting microbial load reduction on treated areas. This specific formula of a 1% aqueous solution is distinct, often positioning the product for applications requiring a mild, water-based antiseptic.

Formulation Type and General Antiseptic Purpose

Solubacter 1% is consistently formulated as an aqueous solution designed exclusively for local/topical application to the skin and mucous membranes. This water-based preparation ensures the solution is engineered for external use where a gentler vehicle is required.

The general purpose of the product is to provide effective antiseptic cleaning, a function derived from its bacteriostatic activity. This action involves inhibiting the growth and reproduction of susceptible microorganisms. Consequently, Solubacter 1% is typically utilized in general scenarios that require local surface hygiene and microbial management.

What side effects are possible with Solubacter 1%?

Possible Side Effects and Safety Information

The safety profile of Solubacter 1% (Triclocarban 1%) is defined by both localized adverse reactions and high-level systemic concerns reviewed by government regulatory bodies. Official safety findings, often derived from assessments by the U.S. Food and Drug Administration (FDA) and European health authorities, classify the potential risks related to this active ingredient.

Officially Documented Safety Concerns

The most commonly observed adverse reactions are those related to topical application, primarily involving the Skin and Subcutaneous Tissue Disorders system. These reactions include local skin irritation and contact dermatitis.

Category Regulatory Focus
Systemic Concern Potential for Endocrine Disruption
Absorption Confirmed systemic absorption is higher than previously estimated
Time Constraint Safety was not demonstrated for long-term daily use

Safety assessments have documented the active ingredient's absorption through the skin, leading to regulatory concern over its potential systemic impact, particularly on the Endocrine System. Population-specific considerations also address potential sensitization risk in children and systemic effects in individuals of reproductive age.

The regulatory profile emphasizes that a significant safety constraint is tied to the duration of exposure. Official documents cite the need for caution, as safety has not been established for chronic, daily, or long-term application. The overall safety structure is thus organized around these duration-dependent restrictions and the high-level potential for systemic effects.

Overdose and Emergency Response

Overdose and When to Seek Help

The official information regarding overdose is derived from the acute toxicological and regulatory safety assessments of the active ingredient, Triclocarban, as documented by health authorities.

Domain Official Regulatory Statements
Documented Overdose Presentations Acute oral exposure to the neat substance is officially classified as a low ingestion hazard based on acute toxicity data reviewed by health authorities. Acute, high-dose exposure in regulatory studies has formally documented systemic signs, including tremor and decreased activity in animal models.
Physiological Systems Affected High-dose toxicological review indicates potential systemic effects on the neurological system and organ toxicity involving the liver, spleen, and kidney, as observed in animal studies used for regulatory classification.
Population-Specific Overdose Severe exposure has a historical association with neonatal methemoglobinemia, which represents a severe outcome risk for a specific population. Regulatory documents also note concerns regarding potential developmental impacts.
Emergency-Response Statements Management of acute toxicity is defined as symptomatic and supportive, as no specific pharmacological antidote is known for Triclocarban poisoning.
When Immediate Medical Help is Required Urgent medical assessment and supportive care are required immediately upon the observation of any systemic signs of poisoning, such as neurological changes or distress, or any suspected severe exposure, especially in vulnerable populations.

Therapeutic Uses of Solubacter 1%

What Solubacter 1% Treats: Main Uses and Benefits

Hygienic Management and Localized Support

The preparation is considered relevant to the domain of topical antisepsis. Triclocarban is used as an active ingredient in antiseptic wash products, reflecting the agent's core function. Solubacter 1% (Triclocarban 1% aqueous solution) is used to address the condition of having localized susceptible bacteria on the skin and mucous membranes, which represents a need for surface bacterial management. This product is commonly used to help with antiseptic cleaning in conditions that are either infected or show a high risk of superinfection, and for general hygiene in areas requiring reliable local antisepsis. These uses are relevant for minor lesions and superficial abrasions.

Therapeutic Benefits

The product is applied in addressing the need for reduction of microbial presence, which contributes to improved comfort during periods of heightened symptoms and supports local hygiene. The product is relevant in contexts marked by increased discomfort or tension. This solution contributes to easing the overall symptom load related to microbial presence.


Quick Fact: Context for Localized Support

Application Type Symptom Domain Addressed Patient Benefit
Local Adjunctive Care Risk of Superinfection Supports the patient during difficult episodes by easing distress
Hygienic Cleansing Localized Bacteria Presence Contributes to improved day-to-day comfort during symptomatic periods
Contaminated Areas Need for Local Antisepsis Assists with functional stability

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Solubacter 1% — official regulatory information

Eligibility scope

Section Regulatory Status
Populations for whom use is allowed (as stated in label) Health Care Professionals/Settings for applications such as surgical scrubs (conditional use only).
Populations for whom use is not recommended (if applicable) Pregnant Women, Breastfeeding Women, Children, and Adolescents.
Populations for whom use is contraindicated General Consumers for use in Over-the-Counter (OTC) antiseptic wash products.
Age-related eligibility rules Children under 6 years old are subject to restrictions for specific non-rinse-off products containing this ingredient.
Condition-specific eligibility rules No explicit contraindications for severe hepatic or renal impairment are documented in official regulatory labeling.
Pregnancy and lactation eligibility status Not Recommended for both pregnancy and lactation due to the potential for systemic exposure and transfer of an endocrine-disrupting substance.
Eligibility-related restrictions Use is limited by setting (prohibited in consumer washes) and age/physiological status (restricted in vulnerable groups).

Eligibility classifications (high-level)

Classification Description
Eligibility severity classification Contraindicated (for OTC consumer wash use). Restricted/Not Recommended (for vulnerable populations).
Regulatory basis U.S. Food and Drug Administration (FDA) Final Rule and European Commission Scientific Committee on Consumer Safety (SCCS) Opinions.

Resulting eligibility structure

Official eligibility statements:

  • The use of this active ingredient in OTC consumer antiseptic wash products by the general public is contraindicated due to the FDA's Non-GRASE classification.
  • Use is Not Recommended in pregnant or breastfeeding women due to evidence of systemic absorption and potential for developmental effects.
  • Conditional eligibility exists for use in regulated professional settings by health care personnel.

Connection to the overall eligibility profile Official regulatory documents define eligibility based on the intended context of use and the physiological status of the user. The FDA determination sets a prohibition for general public use in consumer washes, while evidence of endocrine activity mandates significant restrictions for pregnant women, breastfeeding women, and all pediatric populations.

What should I know about interactions with other medicines?

Official Regulatory Interaction Profile

The documented interaction profile for Solubacter 1% (Triclocarban) is defined by its substance-level effects rather than typical systemic drug-drug interactions involving metabolic enzymes.

Interaction Type Officially Documented Effect
Pharmacodynamic Interaction The substance is formally classified as an endocrine disruptor and has been shown to amplify the actions of certain steroid hormones through receptor agonism.
Exposure Interaction Widespread use is officially linked to the potential for antimicrobial resistance by favoring the selection and proliferation of drug-resistant bacterial strains.

Interaction-Related Restrictions

The substance is not associated with formal timing or separation requirements with specific medicinal products. However, the U.S. Food and Drug Administration (FDA) has established a prohibition on marketing for over-the-counter consumer wash products containing Triclocarban due to insufficient data supporting its long-term safety and efficacy.

Population-Specific Notes

Cautions for vulnerable populations are officially noted due to the substance's systemic absorption. Regulatory reviews highlight concerns regarding reproductive and developmental impacts based on animal and in vitro studies, with the substance having been detected in human breast milk following use.

Connection to the overall interaction profile

The regulatory profile emphasizes that its primary concerns are tied to pharmacodynamic risks of endocrine disruption and exposure risks of promoting antimicrobial resistance with prolonged daily use. This structure outlines the mandated regulatory constraints on the use of the active substance.

Mechanism of Action

Disruption of Bacterial Cellular Integrity

The action of Solubacter 1% is driven by Triclocarban (TCC), which employs a dual mechanism against local microorganisms. TCC's primary action involves physiochemical disruption of the bacterial cytoplasmic membrane. By integrating into the lipid bilayer, the molecule rapidly compromises the membrane's structural integrity, causing essential internal contents to leak out and leading to a collapse of the cell's Proton Motive Force (PMF). This cascade results in a bactericidal effect by causing rapid cellular energy failure and structural damage, resulting in the inactivation of microorganisms on the applied surface.

Inhibition of Essential Biosynthesis

The drug also exerts a highly specific effect by acting as an enzyme inhibitor against Enoyl-acyl carrier protein (ACP) reductase ( FabI). This enzyme is crucial for the Type II Fatty Acid Synthesis (FAS-II) pathway, which supplies the necessary building blocks for new cell membranes. By blocking FabI, TCC restricts the bacteria's ability to construct new structural components, imposing a bacteriostatic effect that halts growth, division, and reproduction. This mechanism complements the immediate action by restricting microbial population expansion, thereby resulting in local microbial population control.

Dosage and Administration Information

How to Use Solubacter 1%

Solubacter 1% (Triclocarban 1% aqueous solution) is utilized strictly as a topical agent for external application, consistent with its classification as an antiseptic and antimicrobial wash product. The official guidelines for its use are structured around a standardized washing procedure and specific administrative constraints, derived from regulatory labeling for this type of product.


Administration Scope

The approved usage specifies the method, timing, and essential constraints, as published in authoritative drug documentation.

Instruction Detail
Route of Administration Topical application to the skin and mucous membranes.
Dosing Schedule No fixed volumetric dose is specified; the solution is applied in a quantity sufficient to cover the area during cleansing.
Frequency Pattern As-needed or intermittent use for hygienic cleansing.
Special Procedural Conditions The product is strictly for external use only and contact with eyes must be avoided; the area must be rinsed and dried thoroughly after application.

Resulting Procedural Structure

The usage protocol involves a specific sequence of actions to ensure proper application and removal of the topical agent, as outlined in the directions on the official label.

Official Step Sequence:

  • Wetting: The area of application is first wetted.
  • Lathering: The solution is applied to the area and lathered vigorously.
  • Washing: The skin is washed thoroughly.
  • Rinsing: The applied solution is rinsed off well with water.
  • Drying: The application area is dried thoroughly.

This procedural structure governs the administration of Solubacter 1%, defining it as an externally applied wash with use determined by the need for local surface hygiene.

Recent Clinical Evidence

Research evidence / Overview of studies for Solubacter 1%

The research evidence for Solubacter 1% (Triclocarban 1% aqueous solution) primarily describes studies and regulatory evaluations concerning how the active ingredient was evaluated for antiseptic use.

Evidence for Routine Hygienic Cleansing

The evidence for the active ingredient's role in hygienic skin management includes systematic reviews and comparative randomized controlled trials (RCTs). These studies were applied in research contexts involving routine hand and body washing in general community settings. Outcomes studied focused on a microbiological level, monitoring data related to the reduction in transient and resident bacterial counts on the skin surface. Regulatory reviews noted that for many users in a non-healthcare environment, the active ingredient was not consistently linked to a meaningful advantage in preventing infectious illness symptoms compared to non-antimicrobial soap and water.

The principal limitations noted in this body of research include the lack of consistent evidence for added clinical benefit. The long-term effects on human health over years of continuous use are not fully established in the peer-reviewed literature and remain an area requiring further study.

Evidence for Adjunctive Management of Skin Conditions

A separate body of research explored the application of the agent in patients requiring local surface bacterial management. This evidence base is composed of controlled clinical studies and randomized controlled trials. Studies were conducted in research contexts involving fluctuating or unstable symptoms, predominantly focusing on conditions such as Atopic Dermatitis (eczema).

Research examined how symptoms evolved in the observed populations, measuring endpoints related to dermatologic assessment scores and measuring outcomes related to changes in skin colonization by certain susceptible microorganisms. This research base is smaller and more specialized, meaning the results apply only to the specific populations studied. The use evaluated in these studies was typically adjunctive (supportive) to other primary care regimens.

Frequently Asked Questions (FAQ)

Common questions about Solubacter 1% (FAQ)


Q: Does Solubacter 1% contain an antibiotic?

A: Official regulatory documents classify the active ingredient in Solubacter 1%, Triclocarban, as an antiseptic and an antimicrobial agent. This designation means its purpose is to reduce microorganisms on the skin's surface. While it has an antibacterial property, it is not formally classified as a systemic antibiotic drug.


Q: Is Solubacter 1% available without a prescription?

A: The U.S. Food and Drug Administration (FDA) determined that the active ingredient, Triclocarban, was not generally recognized as safe and effective (GRASE) for consumer antiseptic wash use. This determination resulted in its removal from most over-the-counter (OTC) consumer antiseptic wash products.


Q: Do children have different reactions to Solubacter 1% than adults?

A: Regulatory authorities have noted the need for caution when the active ingredient is used in pediatric populations. Official information has established specific restrictions for use in children, such as a warning for products containing Triclocarban not to be used for children under six years of age.


Q: What if Solubacter 1% gets in my eyes or mouth?

A: Official product labels indicate that if eye contact occurs, the area should be flushed thoroughly with water immediately, as the product is strictly for external use. If Solubacter 1% is accidentally swallowed, official safety guidance advises contacting medical help or a Poison Control Center right away.


Q: Are there any specific ingredients in Solubacter 1% that people are usually allergic to?

A: The official product label, which includes all ingredients, is the reference for potential allergens. Official documents indicate that the inactive ingredients may contain common sensitizers, such as specific fragrances or color additives. The full ingredient list can be reviewed in the official product information.


Q: Is the main ingredient in Solubacter 1% a common dermatology medication?

A: The active ingredient is classified as a broad-spectrum antimicrobial and antiseptic agent. Regulatory documentation indicates that the substance was initially developed for use in professional settings, such as surgical scrubs in the medical field, rather than solely for general patient dermatology use.


Q: What is the usual recommended length of treatment with Solubacter 1%?

A: According to official regulatory documents, Solubacter 1% is indicated for as-needed or intermittent use. Safety has not been established for chronic, continuous, or long-term daily application due to insufficient data regarding prolonged exposure risks.


Q: What is the risk of overdose if too much Solubacter 1% is applied?

A: Official regulatory reviews note that the active ingredient in Solubacter 1% is absorbed through the skin. Regulatory reviews suggest that using the product excessively or chronically may increase systemic exposure, which raises the potential for unintended effects on the body's systems.


Q: Does Solubacter 1% interact with common cosmetic products?

A: Regulatory bodies have established maximum concentration limits for the active ingredient when it is included in certain cosmetic and personal care products, such as soaps and toothpaste. This regulatory structure is in place to manage the risk of potential overexposure from using multiple products that contain the same active substance.


Q: Can Solubacter 1% be used on open wounds or broken skin?

A: Official product uses are generally described for hygienic cleansing of the skin to decrease bacteria. Official information does not contain specific instructions or indications for using the product on deeply open wounds, puncture wounds, or broken skin.


Q: Is it normal if Solubacter 1% feels sticky or oily after application?

A: Solubacter 1% is officially formulated as an aqueous solution or a soap bar. If the product is applied and thoroughly rinsed off with water as described in the use protocol, it is not typically characterized by a sticky or oily feel remaining on the skin.

How should Solubacter 1% be stored and disposed of?

Solubacter 1% (Triclocarban) must be stored and disposed of according to strict regulatory guidelines to maintain product quality and protect the environment.

Storage Requirements

The product must be stored below 110 F (mathbf43 C), as stated in official labeling for Triclocarban-containing over-the-counter products. It is necessary to keep the medicine out of the sight and reach of children; emergency medical assistance or a Poison Control Center must be contacted if the product is swallowed. The product should be protected from direct sunlight, and care should be taken during storage, as the container's contents may discolor certain fabrics or surfaces.

Disposal Instructions

Disposal of any unused or expired Solubacter 1% and its container must comply with all local, regional, and national regulations. Due to the environmental hazard classification of Triclocarban—as it is very toxic to aquatic life with long lasting effects—release to the environment, such as disposal into household wastewater, must be strictly avoided.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Solubacter 1% found in:

A-Z Index: